When should high-grade heart block trigger a search for a treatable cardiomyopathy?
作者信息
Cooper Leslie T, Blauwet Lori A
出版信息
Circ Arrhythm Electrophysiol. 2011 Jun;4(3):260-1. doi: 10.1161/CIRCEP.111.963249.
Abstract
摘要
相似文献
1
When should high-grade heart block trigger a search for a treatable cardiomyopathy?何时高度房室传导阻滞应促使寻找可治疗的心肌病？
Circ Arrhythm Electrophysiol. 2011 Jun;4(3):260-1. doi: 10.1161/CIRCEP.111.963249.
2
Hypertrophic cardiomyopathy presenting with 3rd-degree atrioventricular block.肥厚型心肌病伴三度房室传导阻滞。
Tex Heart Inst J. 1997;24(4):372-5.
3
[Evolution of hypertrophic cardiomyopathy after application of an artificial pacemaker. Physiopathological and therapeutic aspects].
Minerva Cardioangiol. 1982 Oct;30(10):569-74.
4
Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病患者经皮腔内室间隔心肌消融术并发完全性心脏传导阻滞的保守治疗
Am J Cardiol. 2004 Oct 1;94(7):982. doi: 10.1016/j.amjcard.2004.05.013.
5
Familial hypertrophic cardiomyopathy associated with spontaneous complete heart block.家族性肥厚型心肌病合并自发性完全性心脏传导阻滞。
J Med Assoc Thai. 1991 Jul;74(7):301-5.
6
Abrupt aggravation of atrioventricular block and syncope in hypertrophic cardiomyopathy.肥厚型心肌病患者房室传导阻滞及晕厥的突然加重
Arch Dis Child. 1995 Dec;73(6):536-7. doi: 10.1136/adc.73.6.536.
7
[Familial complete atrioventricular block in patients with hypertrophic cardiomyopathy].肥厚型心肌病患者的家族性完全性房室传导阻滞
Arq Bras Cardiol. 1992 Sep;59(3):209-13.
8
Pacemaker therapy in a pediatric patient with hypertrophic obstructive cardiomyopathy and rapid intrinsic atrioventricular conduction.
Pediatr Cardiol. 1999 May-Jun;20(3):229-31. doi: 10.1007/s002469900450.
9
Hypertrophic cardiomyopathy complicated by complete heart block. Case report and review of the literature.
S Afr Med J. 1984 Dec 1;66(22):847-55.
10
Complete Heart Block in Hypertrophic Cardiomyopathy: A Rare Association.肥厚型心肌病中的完全性心脏传导阻滞：一种罕见的关联。
Kathmandu Univ Med J (KUMJ). 2015 Oct-Dec;13(52):372-4. doi: 10.3126/kumj.v13i4.16841.
引用本文的文献
1
Dysrhythmias associated with COVID-19: Review and management considerations.与 COVID-19 相关的心律失常：综述及处理要点。
Am J Emerg Med. 2023 Feb;64:161-168. doi: 10.1016/j.ajem.2022.12.004. Epub 2022 Dec 5.
2
Management of Arrhythmias Associated with COVID-19.与 COVID-19 相关的心律失常的管理。
Curr Cardiol Rep. 2020 Nov 24;23(1):2. doi: 10.1007/s11886-020-01434-7.
3
Strategies for Managing Arrhythmias in Patients with Cardiac Sarcoidosis.心脏结节病患者心律失常的管理策略
J Innov Card Rhythm Manag. 2019 Jan 15;10(1):3495-3502. doi: 10.19102/icrm.2019.100105. eCollection 2019 Jan.
4
Heart Brake: An Unusual Cardiac Manifestation of COVID-19.心脏骤停：新型冠状病毒肺炎一种不寻常的心脏表现
JACC Case Rep. 2020 Jul 15;2(9):1252-1255. doi: 10.1016/j.jaccas.2020.04.026. Epub 2020 May 3.
5
A complete heart block in a young male: a case report and review of literature of cardiac sarcoidosis.一名年轻男性的完全性心脏传导阻滞：心脏结节病病例报告及文献综述
Heart Fail Rev. 2017 Jan;22(1):55-64. doi: 10.1007/s10741-016-9585-0.
6
Management of Arrhythmias in Cardiac Sarcoidosis.心脏结节病心律失常的管理
Clin Cardiol. 2015 Oct;38(10):635-40. doi: 10.1002/clc.22430. Epub 2015 Jul 14.
7
Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis.心电图标测引导：一种提高疑似心脏结节病和心肌炎心内膜心肌活检的精准度和诊断率的方法。
JACC Heart Fail. 2014 Oct;2(5):466-73. doi: 10.1016/j.jchf.2014.03.015. Epub 2014 Sep 3.
8
Idiopathic giant cell myocarditis and cardiac sarcoidosis.特发性巨细胞性心肌炎和心脏结节病。
Heart Fail Rev. 2013 Nov;18(6):733-46. doi: 10.1007/s10741-012-9358-3.
本文引用的文献
1
Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.心脏结节病和巨细胞性心肌炎导致年轻和中年成人房室传导阻滞。
Circ Arrhythm Electrophysiol. 2011 Jun;4(3):303-9. doi: 10.1161/CIRCEP.110.959254. Epub 2011 Mar 22.
2
Cardiac sarcoidosis.心脏结节病
Am Heart J. 2009 Jan;157(1):9-21. doi: 10.1016/j.ahj.2008.09.009. Epub 2008 Nov 12.
3
Usefulness of immunosuppression for giant cell myocarditis.免疫抑制疗法对巨细胞性心肌炎的有效性
Am J Cardiol. 2008 Dec 1;102(11):1535-9. doi: 10.1016/j.amjcard.2008.07.041. Epub 2008 Sep 18.
4
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.心内膜心肌活检在心血管疾病管理中的作用：美国心脏协会、美国心脏病学会和欧洲心脏病学会的科学声明。
Circulation. 2007 Nov 6;116(19):2216-33. doi: 10.1161/CIRCULATIONAHA.107.186093. Epub 2007 Oct 24.
5
Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance.通过心血管磁共振评估结节病中心肌炎症和瘢痕形成的模式。
Heart. 2006 Mar;92(3):399-400. doi: 10.1136/hrt.2004.058016.
6
A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy.结节病的心肌内膜活检结果呈阳性与最初病因不明的心肌病患者的预后不良相关。
Am Heart J. 2005 Sep;150(3):459-63. doi: 10.1016/j.ahj.2004.10.006.
7
Cardiac sarcoidosis: spectrum of MRI features.心脏结节病：MRI特征谱
AJR Am J Roentgenol. 2005 Jan;184(1):249-54. doi: 10.2214/ajr.184.1.01840249.
8
Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.禁食状态下18F-FDG PET在心脏结节病诊断中的应用价值
J Nucl Med. 2004 Dec;45(12):1989-98.
9
A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis.心脏结节病与特发性巨细胞心肌炎的临床及组织病理学比较
J Am Coll Cardiol. 2003 Jan 15;41(2):322-9. doi: 10.1016/s0735-1097(02)02715-8.
10
Endomyocardial biopsy findings in 50 patients with idiopathic atrioventricular block: presence of myocarditis.50例特发性房室传导阻滞患者的心内膜心肌活检结果：存在心肌炎。
Jpn Heart J. 2001 Nov;42(6):691-700. doi: 10.1536/jhj.42.691.
Zotero 插件